DOCSLIB.ORG

Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles, Third Edition Edited by Arthur K

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Cambridge University Press 0521793513 - Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles, Third Edition Edited by Arthur K. Asbury, Guy M. McKhann, W. Ian McDonald, Peter J. Goadsby and Justin C. McArthur Index More information Index Note: this is a complete two-volume index Note: page numbers in italics refer to figures and tables; ‘Fig.’ refers to illustrations in the plates section Abbreviations of conditions used in subheadings (without explanation): AD Alzheimer’s disease AIDS Acquired immune deficiency syndrome ALS Amyotrophic lateral sclerosis CJD Creutzfeldt–Jakob disease FTD Frontotemporal dementia HIV Human immunodeficiency virus HD Huntington’s disease PD Parkinson’s disease SIADH syndrome of inappropriate secretion of antidiuretic hormone A-fibres 873–4 abdominoperineal resection of carcinoma acetaminophen activation 875 846 migraine 1940 brain-derived nerve growth factor 884, abducens motoneurons 636 shingle pain 1678 885 abducens nerve acetazolamide sprouted 885, Fig. 58.12 fascicle lesions 650 acidification 1235 A2M genetic locus 5 middle ear disease 670 idiopathic intracranial hypertension A␣ fibres 874 palsy 649–51 2027 A␤ antibody passive transfer 1853–4 petrous bone infection 651 periodic paralysis 1201–2 A␤ fibres 874 abducens nucleus acetyl CoA 1210 AD 1844 abducens nerve palsy 649 acetylcholine formation in familial AD 1845 horizontal conjugate eye movements AD 256 see also amyloid 635, 636, 637 brain aging 198 A␤ immunization 1853–4 lesions 635 Lewy body dementia 273, 274 A␤ peptide 12, 215 oculomotor nerve neurons 647, 648 neuromuscular junction 1143, 1144 AD 255–6, 257, 258 abetalipoproteinemia 1139–40, 1882, olfactory deficit 604 clearance 229 1883 parasympathetic system 1341, 1342 degradation/clearance stimulation 262 abulia 1962 quantal release 1143–4 immunization against 262 acamprosate, alcoholism treatment 441, release at neuromuscular junction production blocking 262 1821 1143–4 see also A␤ amyloid plaques acanthocytosis 1882 swallowing 800 A␤42 acceleration, rotational in brain injury acetylcholine receptor (AChR) 1143, 1144, AD 1844, 1846 1799 1144–6 CSF levels 262 acetaldehyde 1820, 1821 antibody assay 1150–1 ABCC gene mutations 1412 acetaldehyde–protein adducts 1821 channel abnormalities 1145 973 © Cambridge University Press www.cambridge.org Cambridge University Press 0521793513 - Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles, Third Edition Edited by Arthur K. Asbury, Guy M. McKhann, W. Ian McDonald, Peter J. Goadsby and Justin C. McArthur Index More information 974 Index acetylcholine receptor (cont.) onset 1673 infantile spasms 1240 clustering at neuromuscular junction optic neuritis 1674–5 obsessive–compulsive disorder 394 1145 acyclovir pituitary adenoma 859–60 deficiency 1155–7 herpes simplex encephalitis 1671 rapid stimulation test 864 myasthenia gravis 1148, 1520 herpes simplex meningitis 1664 secretion 854 acetylcholinesterase 1143, 1146 acyl-CoA dehydrogenase deficiency adrenoleukodystrophy 1138, 1882 end-plate deficiency 1160 short-chain 1221 neonatal 1633, 1913 achondroplasia very-long chain 1220 X-linked 1633–6, 1913 craniocervical junction anomaly 732 acyl-CoA oxidase deficiency 1913 adrenal function 1635, 2039 low back pain 763 acylcarnitines, long-chain 1219 animal model 1635 achromatopsia 627, 628 adamalysins 1511 bone marrow transplantation 1635–6 acid maltase deficiency 1208, 1217 addiction 431 clinical features 1633–4 acoustic neuroma definition 916 diagnosis 1635 auditory nerve degeneration 673 glutamate pathways 440 dietary therapy 1636 childhood 1449 Addison’s disease 1175, 2039 gene defect 1634–5 pain 940 Guillain–Barré syndrome 2039 imaging 1635, 1636 radiotherapy 1494 addressins 1595 pathology/pathogenesis 1635 surgery 674 adeno-associated virus vaccine against phenotypes 1634 acoustic reflex thresholds 666, 668 NR1 subunit 68 therapy 1635–6 acousticomotor system 663 adenosine adrenomyeloneuropathy 1138, 1633–4, acrodermatitis chronica atrophicans 1757 alcohol intoxication 1819 1635 acromegaly 858–9 cerebral blood flow regulation 1337–8 adrenal function 2039 glucose-GH suppression test 855, 859 peripheral sensitization 880 ataxia 1891 acrylamide neuropathy 1082–3, 1104 sleep promotion 819 bone marrow transplant actin 1163 adenosine diphosphate 1207 contraindication 1636 fibrous (f-actin) 90 muscle glycolytic defects 1211 adult T-cell leukemia 1710–11 ␣-actin gene 1171–2 adenosine triphosphate advanced sleep phase syndrome 825 action potentials hydrolysis 1207 Advanced Trauma Life Support (ATLS) bursts in nervous system lesions 897 muscle fatigue 1209 1796 compound muscle 1111, 1157, 1159 adenosyl cobalamin system 2046 aerobic fitness 1210 orthodromic 877 adhalin deficiency 1167 affective disorders see mood disorders propagated and potassium flow 1195 adhesion molecules age-related changes propagation to spinal cord 878 bacterial meningitis 1733 accumulation 242 saltatory conduction 1077, 1078, 1595 viral infection 1655 intrinsic 240–2 fast 876, Fig. 58.5 adjustment disorders 364 molecular mechanisms 239–42 actions, meaningful 472 adoption studies 15 ageusia 614 activation-flow coupling (AFC) 131, 132 adrenal disease, neurological thalamus injury 615 spatial extent 136 complications 2038–40 aggression activator-complex protein-1 (AP-1) 1436 adrenal hormone replacement therapy attention deficit hyperactivity disorder activities of daily living 1635 423 AD 254 adrenal insufficiency periaqueductal grey 890 dementia 245 hypercalcemia 2004 aggressive outbursts 1283, 1284 acupuncture hyperkalemia 2010–11 aging dystonia 543 secondary 862 alpha frequency 238 pain control 917 SIADH differential diagnosis 868 Alzheimer’s disease 253 acute disseminated encephalitis 1529 suspected secondary 864 anatomical changes 237–9 acute disseminated encephalomyelitis adrenalectomy, bilateral 860 apoptosis 241 ␣ 1514, 1624, 1673–5 2-adrenergic agonists 913 brain 237–8 imaging 1673–4 ␤-adrenergic receptor 26 caloric restriction 241 management 1674 ␣-adrenoceptors, cerebral circulation cellular basis 241 multiple sclerosis differential diagnosis 1343 cerebral blood flow 238 1624 adrenocorticotrophic hormone (ACTH) dementia 237–46, 242–3 © Cambridge University Press www.cambridge.org Cambridge University Press 0521793513 - Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles, Third Edition Edited by Arthur K. Asbury, Guy M. McKhann, W. Ian McDonald, Peter J. Goadsby and Justin C. McArthur Index More information Index 975 risk factor 246 albinism, optic chiasm disorders 625 antisocial personality disorder electroencephalogram 238 albuterol in facioscapulohumeral relationship 1820 estrogens 242 muscular dystrophy 1169, 1172 central pontine myelinolysis 1823 focal temporal slowing 238 alcohol/alcohol abuse 1814 disulfiram sensory–motor genetic basis 243 addiction 440–1 polyneuropathy 1102 neural growth factors 241–2 acute mechanisms 442 dopamine 440 neurodegeneration 210–11 autonomic dysfunction 787 epidemiology 1814 neurotransmitter function 238–9 binge drinking 1817, 1824 ethanol resistance 1815 olfactory dysfunction 600, 603 cerebellar degeneration 1823 ethanol tolerance 1815 penetrating artery disease syndromes dopamine levels in nucleus acumbens genetic risk 1820 1356 432 genetics 1820 physiological changes 237–9 drug abuse 1834, 1835 Marchiafava–Bignami disease 1823 aging population 3 endorphins 440 treatment 441, 1820–1 agnosia, visual associated 628–9 epidemiology 1814 see also fetal alcohol syndrome agraphia 321 epilepsy 1255 aldolase A deficiency 1217 agrin 1145 essential tremor 518 aldosterone 2011 AIDS hypomagnesemia 2008 ALDP protein 1634 cytomegalovirus polyradiculitis intoxication 438, 1814–16 alertness 294 1085 benign paroxysmal positional vertigo Alexander disease 1642–4 dementia complex 1690–6 differential diagnosis 687 alexia 324 epidemic 3, 4, 123 severe 1815–16 primary reading epilepsy 1258 epidemiology 1683 intraneural injection for multiple algal blooms 1809, 1810 gracile tract degeneration 1082 sclerosis 1625 alien limb phenomenon, corticobasal neurological manifestations 123 kinetic tremor 519 degeneration 495–6 orphans 3 level of response (LR) 1820 ALK1 gene 2075 pandemic 1685 neurotoxicity 1814–24 allelic association 19, 20 peripheral neuropathy 1081 olfaction 599 allelic heterogeneity 14–15 sensory neuropathy 1093 opiate mechanisms in reward 440 allesthesia 332 vacuolar myelopathies 722 optic neuropathy 624 testing 334 see also HIV infection pharyngeal muscle tone suppression allokinesia testing 334 air emboli 1944–5 822 allopurinol, azathioprine interaction 1532 air travel 4 reward 433 Alpers disease 1919 airway patency, sleep 821 stroke 1943 alpha beta-crystalline 1643 akathisia 2045 primary prevention 1416 alpha frequency, aging 238 akinesia 333 tolerance 1815 Alport syndrome 672 corticobasal degeneration 495 withdrawal 433, 438 alprostadil 848 directional 333 delirium tremens 517 altered peptide ligands (APLs) 1508 hemispatial 333 nightmares 827 immunomodulation 1543 liver transplantation 1976 NMDA transmission 441 alternative therapies pathophysiology 336–7 REM sleep behaviour disorder 828 cerebral palsy 577 akinetic mutism seizures 440 dystonia 543 attention 293 syndrome 1816–17 pain control 917 awakeness 293 alcohol dehydrogenase (ADH) 1820 aluminium cingulate gyri 337 alcoholic blackouts 1815 accumulation 241, 1996 consciousness 295, 296 alcoholic dementia 1823 intoxication 1998 frontal lobes 337 alcoholic flush reaction 1820 serum levels 1996 medial thalamus 337 alcoholic myopathy 1824 alveolar
Recommended publications
  • NBD-17-173R1 Title

    NBD-17-173R1 Title

    Elsevier Editorial System(tm) for Neurobiology of Disease Manuscript Draft Manuscript Number: NBD-17-173R1 Title: KCC3 loss-of-function contributes to Andermann syndrome by inducing activity-dependent neuromuscular junction defects Article Type: Research paper Keywords: Motoneuron; Andermann syndrome; chloride homeostasis; electrical activity; neuromuscular junction; Na+/K+ ATPase Corresponding Author: Dr frederique scamps, Corresponding Author's Institution: Inserm First Author: Mélissa Bowerman Order of Authors: Mélissa Bowerman; Céline Salsac; Véronique Bernard; Claire Soulard; Annie Dionne; Emmanuelle Coque; Salim Benlefki; Pascale Hince; Patrick Dion; Gillian Butler-Browne; William Camu; Jean-Pierre Bouchard; Eric Delpire; Guy Rouleau; Cédric Raoul; frederique scamps Abstract: Loss-of-function mutations in the potassium-chloride cotransporter KCC3 lead to Andermann syndrome, a severe sensorimotor neuropathy characterized by areflexia, amyotrophy and locomotor abnormalities. The molecular events responsible for axonal loss remain poorly understood. Here, we establish that global or neuron-specific KCC3 loss-of-function in mice leads to early neuromuscular junction (NMJ) abnormalities and muscular atrophy that are consistent with the pre- synaptic neurotransmission defects observed in patients. KCC3 depletion does not modify chloride handling, but promotes an abnormal electrical activity among primary motoneurons and mislocalization of Na+/K+-ATPase α1 in spinal cord motoneurons. Moreover, the activity-targeting drug carbamazepine restores Na+/K+-ATPase α1 localization and reduces NMJ denervation in Slc12a6-/- mice. We here propose that abnormal motoneuron electrical activity contributes to the peripheral neuropathy observed in Andermann syndrome. Cover Letter Dear Editor Thank you for your interest in this study. We have answered to all the points addressed by the Referees. We now provide discussion and references concerning the pertinence of using motoneuron primary culture relative to recordings from post-natal or adult spinal cord slices.
  • Peripheral Neuropathy in Complex Inherited Diseases: an Approach To

    Peripheral Neuropathy in Complex Inherited Diseases: an Approach To

    PERIPHERAL NEUROPATHY IN COMPLEX INHERITED DISEASES: AN APPROACH TO DIAGNOSIS Rossor AM1*, Carr AS1*, Devine H1, Chandrashekar H2, Pelayo-Negro AL1, Pareyson D3, Shy ME4, Scherer SS5, Reilly MM1. 1. MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, UK. 2. Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, UK. 3. Unit of Neurological Rare Diseases of Adulthood, Carlo Besta Neurological Institute IRCCS Foundation, Milan, Italy. 4. Department of Neurology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA 5. Department of Neurology, University of Pennsylvania, Philadelphia, PA 19014, USA. * These authors contributed equally to this work Corresponding author: Mary M Reilly Address: MRC Centre for Neuromuscular Diseases, 8-11 Queen Square, London, WC1N 3BG, UK. Email: [email protected] Telephone: 0044 (0) 203 456 7890 Word count: 4825 ABSTRACT Peripheral neuropathy is a common finding in patients with complex inherited neurological diseases and may be subclinical or a major component of the phenotype. This review aims to provide a clinical approach to the diagnosis of this complex group of patients by addressing key questions including the predominant neurological syndrome associated with the neuropathy e.g. spasticity, the type of neuropathy, and the other neurological and non- neurological features of the syndrome. Priority is given to the diagnosis of treatable conditions. Using this approach, we associated neuropathy with one of three major syndromic categories - 1) ataxia, 2) spasticity, and 3) global neurodevelopmental impairment. Syndromes that do not fall easily into one of these three categories can be grouped according to the predominant system involved in addition to the neuropathy e.g.
  • Neuro-Ophthalmology-Email.Pdf

    Neuro-Ophthalmology-Email.Pdf

    NEURO- OPHTHALMOLOGY Edited by DESMOND P. KIDD, MD, FRCP Consultant Neurologist Department of Clinical Neurosciences Royal Free Hospital and University College Medical School London, United Kingdom NANCY J. NEWMAN, MD LeoDelle Jolley Professor of Ophthalmology Professor of Ophthalmology and Neurology Instructor in Neurological Surgery Emory University School of Medicine Atlanta, Georgia VALE´RIE BIOUSSE, MD Cyrus H. Stoner Professor of Ophthalmology Professor of Ophthalmology and Neurology Emory University School of Medicine Atlanta, Georgia 1600 John F. Kennedy Blvd. Ste 1800 Philadelphia, PA 19103-2899 NEURO-OPHTHALMOLOGY ISBN: 978-0-7506-7548-2 Copyright # 2008 by Butterworth-Heinemann, an imprint of Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Permissions may be sought directly from Elsevier’s Rights Department: phone: (þ1) 215 239 3804 (US) or (þ44) 1865 843830 (UK); fax: (þ44) 1865 853333; e-mail: [email protected]. You may also complete your request on-line via the Elsevier website at http://www.elsevier.com/permissions. Notice Knowledge and best practice in this field are constantly changing. As new research and experience broaden our knowledge, changes in practice, treatment and drug therapy may become necessary or appropriate. Readers are advised to check the most current information provided (i) on procedures featured or (ii) by the manufacturer of each product to be administered, to verify the recommended dose or formula, the method and duration of administration, and contraindications.
  • Exploring Sensory Neuroscience Through Experience and Experiment

    Exploring Sensory Neuroscience Through Experience and Experiment

    The Journal of Undergraduate Neuroscience Education (JUNE), Fall 2012, 11(1):A126-A131 ARTICLE Exploring Sensory Neuroscience Through Experience and Experiment Robert A. Wyttenbach Department of Neurobiology and Behavior, Cornell University, Ithaca, NY 14853. Many phenomena that we take for granted are illusions — attempts to connect them to neuroscience, and shows how color and motion on a TV or computer monitor, for students can explore and experiment with them. Even example, or the impression of space in a stereo music when (as is often the case) there is no agreed-upon recording. Even the stable image that we perceive when mechanistic explanation for an illusion, students can form looking directly at the real world is illusory. One of the hypotheses and test them by manipulating stimuli and important lessons from sensory neuroscience is that our measuring their effects. In effect, students can experiment perception of the world is constructed rather than received. with illusions using themselves as subjects. Sensory illusions effectively capture student interest, but how do you then move on to substantive discussion of Key words: illusion, adaptation, aftereffect, receptive field, neuroscience? This article illustrates several illusions, motion, color, pitch, size, orientation In addition to their immediate aesthetic appeal, illusions adaptation, you move your head closer to or further from have historically been used to investigate mechanisms of the white screen or look at the sky? (6) If you adapt one perception. While the success of this approach has been eye with the other eye closed and then switch eyes, is mixed — many illusions do not have accepted explanations there an afterimage? or turn out to be more complex than initially thought — Interpretations: (1) Students should be able to predict illusions are still powerful teaching tools.
  • 2017PNS Final Programme W

    2017PNS Final Programme W

    2017 PNS Annual Meeting 8-12 July | Sitges, Spain Programme and Abstracts Programme Programme and Abstracts 2017 PNS Annual Meeting 8 – 12 July Sitges, Spain Welcome On behalf of the Peripheral Nerve Society, we are delighted to welcome you to the 2017 Annual Meeting at the Meliá in Sitges, Spain. The PNS Annual Meeting continues to be the premier meeting for cutting-edge innovation and advances in peripheral neuropathy. The 2017 Meeting will provide a mixture of excellent plenary lectures, oral platforms, oral posters, poster sessions, an education course and dedicated symposia organised by special interest groups for Charcot Marie Tooth and related neuropathies (CMTR), the Inflammatory Neuropathy Consortium (INC) and diabetes. There will also be clinical trials update sessions and a hot topic symposium. We look forward to you being part of it. Join us for the Opening Ceremony on Saturday, 8 July, from 18.00 to 20.00, in the Auditorium Hall. The reception will feature complimentary drinks and hors d’oeuvres. Coffee breaks and lunch for registrants will only be provided daily for registrants. Please see the programme for details. Complimentary internet will be provided. Instructions for access can be found on page 11 of the programme. Be sure to attend the Business Meeting on Monday at 13.00 in the Main Auditorium. We will be reviewing Society business, and your input is needed. Monday night, the PNS will be honoring Junior and new Members of the Society with a cocktail reception from 19.00 to 20.00. For those who have registered for this event during the online registration, please join us for the PNS Closing Dinner on Tuesday, 11 July, from 19.00 to 22.00 in the Tramuntana room.
  • Andermann Syndrome

    Andermann Syndrome

    Andermann syndrome Description Andermann syndrome is a disorder that damages the nerves used for muscle movement and sensation (motor and sensory neuropathy). Absence (agenesis) or malformation of the tissue connecting the left and right halves of the brain (corpus callosum) also occurs in most people with this disorder. People affected by Andermann syndrome have abnormal or absent reflexes (areflexia) and weak muscle tone (hypotonia). They experience muscle wasting (amyotrophy), severe progressive weakness and loss of sensation in the limbs, and rhythmic shaking ( tremors). They typically begin walking between ages 3 and 4 and lose this ability by their teenage years. As they get older, people with this disorder frequently develop joint deformities called contractures, which restrict the movement of certain joints. Most affected individuals also develop abnormal curvature of the spine (scoliosis), which may require surgery. Andermann syndrome also results in abnormal function of certain cranial nerves, which emerge directly from the brain and extend to various areas of the head and neck. Cranial nerve problems may result in facial muscle weakness, drooping eyelids (ptosis), and difficulty following movements with the eyes (gaze palsy). Individuals with Andermann syndrome usually have intellectual disability, which may be mild to severe, and some experience seizures. They may also develop psychiatric symptoms such as depression, anxiety, agitation, paranoia, and hallucinations, which usually appear in adolescence. Some people with Andermann syndrome have atypical physical features such as widely spaced eyes (ocular hypertelorism); a wide, short skull (brachycephaly); a high arch of the hard palate at the roof of the mouth; a big toe that crosses over the other toes; and partial fusion (syndactyly) of the second and third toes.
  • Abadie Sign, 400 Abducens Nerve Palsy. See Sixth Nerve Palsy

    Abadie Sign, 400 Abducens Nerve Palsy. See Sixth Nerve Palsy

    Cambridge University Press 978-1-107-01455-8 - Neurologic Differential Diagnosis: A Case-Based Approach Edited by Alan B. Ettinger and Deborah M.Weisbrot Index More information Index Abadie sign, 400 auditory agnosias, 20–1 hallucinations, 189 abducens nerve palsy. See sixth nerve case vignette, 18–19 memory impairment, 233 palsy classification of types, 19 myoclonus related to, 277 abetalipoproteinemia, 301 definition, 18, 39, 408 psychosis related to, 352 abulia, 5 differential diagnosis, 19 amaurosis fugax, 494 acalculia, 39, 433 distinction from aphasia, 39 amnesia, 5 achalasia, 153 for scenes, 19 approach to diagnosis, 223 achromatopsia, 5 for words, 19 case vignette (scopolamine-related acquired hepatocerebral degeneration, tactile agnosia, 21 amnesia), 234 229 visual agnosias, 18–20 case vignettes (transient global acquired neuromyotonia, 282 agnostic alexia, 20 amnesia), 223–34 acrophobia, 349 agoraphobia, 22 definition, 223 acute cardiogenic shock, 378 agraphesthesia, 5 differential diagnosis, 224–33 acute disseminated encephalomyelitis, agraphia, 433 dissociative amnesia, 135–6 226, 532 definition, 39 distinction from delirium, 223 acute inflammatory demyelinating distinction from aphasia, 39 distinction from dementia, 223 polyneuropathy (AIDP), 9, 523, Aicardi syndrome, 353 etiologies, 224–33 551, 565, 569 AIDS, 83, 400 for non-verbal material, 5 acute intermittent porphyria, 229 cognitive impairment, 109 for verbal material, 5 acute pulmonary edema, 378 AIDS myelopathy, 531 transient global amnesia, 225 acute stress disorder,
  • Processes in Biological Vision

    Processes in Biological Vision

    PROCESSES IN BIOLOGICAL VISION: including, ELECTROCHEMISTRY OF THE NEURON This material is excerpted from the full β-version of the text. The final printed version will be more concise due to further editing and economical constraints. A Table of Contents and an index are located at the end of this paper. James T. Fulton Vision Concepts [email protected]/vision April 30, 2017 Copyright 2000 James T. Fulton Environment & Coordinates 2- 1 2. Environment, Coordinate Reference System and First Order Operation 1 The beginning of wisdom is to call things by their right names. - Chinese Proverb The process of communication involves a mutual agreement on the meaning of words. - Charley Halsted, 1993 [xxx rationalize azure versus aqua before publishing ] The environment of the eye can be explored from several points of view; its radiation environment, its thermo- mechanical environment, its energy supply environment and its output signal environment. To discuss the operation of the eye in such environments, establishing certain coordinate systems, functional relationships and methods of notation is important. That is the purpose of this chapter. The reader is referred to the original source for more details on the environment and the coordinate systems. Extensive references are provided for this purpose. Details relative to the various functional operations in vision will be explored in the chapters to follow. Because of the unique integration of many processes by the photoreceptor cells of the retina, which are explored individually in different chapters, a brief section is included here to coordinate this range of material. 2.1 Physical Environment The study of the visual system requires exploring a great many parameters from a variety of perspectives.
  • Toward the Development of a Model to Estimate the Readability of Credentialing-Examination Materials

    Toward the Development of a Model to Estimate the Readability of Credentialing-Examination Materials

    UNLV Theses, Dissertations, Professional Papers, and Capstones 5-2010 Toward the development of a model to estimate the readability of credentialing-examination materials Barbara Anne Badgett University of Nevada Las Vegas Follow this and additional works at: https://digitalscholarship.unlv.edu/thesesdissertations Part of the Educational Psychology Commons Repository Citation Badgett, Barbara Anne, "Toward the development of a model to estimate the readability of credentialing- examination materials" (2010). UNLV Theses, Dissertations, Professional Papers, and Capstones. 185. http://dx.doi.org/10.34917/1436770 This Dissertation is protected by copyright and/or related rights. It has been brought to you by Digital Scholarship@UNLV with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/or on the work itself. This Dissertation has been accepted for inclusion in UNLV Theses, Dissertations, Professional Papers, and Capstones by an authorized administrator of Digital Scholarship@UNLV. For more information, please contact [email protected]. TOWARD THE DEVELOPMENT OF A MODEL TO ESTIMATE THE READABILITY OF CREDENTIALING-EXAMINATION MATERIALS by Barbara A. Badgett Bachelor of Science University of Nevada, Las Vegas 2000 Master of Science University

  • C:\Vision\17Performance Pt 1A.Wpd

    PROCESSES IN BIOLOGICAL VISION: including, ELECTROCHEMISTRY OF THE NEURON This material is excerpted from the full β-version of the text. The final printed version will be more concise due to further editing and economical constraints. A Table of Contents and an index are located at the end of this paper. James T. Fulton Vision Concepts [email protected] April 30, 2017 Copyright 2003 James T. Fulton Performance Descriptors 17- 1 [xxx reconfirm all Section references to or in 17.2.2, etc. ] [xxx reword references to constant quantum efficiency ] 17 Performance descriptors of Vision1 Probably more error has crept into the subject of colour vision from inexact description of experimental conditions and the nature of the stimuli employed than from any other cause. Sir John Parsons, 1915 Because of the amount of color artwork in this chapter, it has been necessary to divide it into three parts for distribution over the INTERNET. PART 1A: INTRO, LUMINANCE & NEW CHROMATICITY DIAGRAM PART 1B: EXTENSIONS TO THE NEW CHROMATICITY DIAGRAM PART 2: TEMPORAL AND SPATIAL DESCRIPTORS OF VISION PART 1A: INTRO. LUMINANCE & CHROMINANCE The press of work on other parts of the manuscript may delay the final cleanup of this PART but it is too valuable to delay its release for comment. Any comments are welcome at [email protected]. 17.1 Introduction This Chapter and Chapter 16 form a pair. While the last Chapter developed equations that are applicable to any animal, this Chapter will concentrate on the most highly developed performance descriptors, those applicable to the human. The visual system is considerably more capable, more flexible and more complex than reflected in even the scientific literature.

  • A Role for KCC3 in Maintaining Cell Volume of Peripheral Nerve Fibers

    Neurochemistry International 123 (2019) 114e124 Contents lists available at ScienceDirect Neurochemistry International journal homepage: www.elsevier.com/locate/nci A role for KCC3 in maintaining cell volume of peripheral nerve fibers * Bianca Flores, Cara C. Schornak, Eric Delpire Neuroscience Graduate Program and Department of Anesthesiology, Vanderbilt University School of Medicine, Nashville, TN 37232, United States article info abstract Article history: The potassium chloride cotransporter, KCC3, is an electroneutral cotransporter expressed in the pe- þ À Received 18 December 2017 ripheral and central nervous system. KCC3 is responsible for the efflux of K and Cl in neurons to help Received in revised form maintain cell volume and intracellular chloride levels. A loss-of-function (LOF) of KCC3 causes Hereditary 17 January 2018 Motor Sensory Neuropathy with Agenesis of the Corpus Callosum (HMSN/ACC) in a population of in- Accepted 17 January 2018 dividuals in the Charlevoix/Lac-Saint-Jean region of Quebec, Canada. A variety of mouse models have Available online 31 January 2018 been created to understand the physiological and deleterious effects of a KCC3 LOF. Though this KCC3 LOF in mouse models has recapitulated the peripheral neuropathy phenotype of HMSN/ACC, we still know Keywords: KCC3 little about the development of the disease pathophysiology. Interestingly, the most recent KCC3 mouse HMSN/ACC model that we created recapitulated a peripheral neuropathy-like phenotype originating from a KCC3 ACCPN gain-of-function (GOF). Despite the past two decades of research in attempting to understand the role of Andermann syndrome KCC3 in disease, we still do not understand how dysfunction of this cotransporter can lead to the T991A pathophysiology of peripheral neuropathy.
  • The Andermann Syndrome: Agenesis of the Corpus Callosum Associated with Mental Retardation and Progressive Sensorimotor Neuronop

    The Andermann Syndrome: Agenesis of the Corpus Callosum Associated with Mental Retardation and Progressive Sensorimotor Neuronop

    LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES The Andermann Syndrome: Agenesis of the Corpus Callosum Associated with Mental Retardation and Progressive Sensorimotor Neuronopathy Albert Larbrisseau, Michel Vanasse, Pierre Brochu and Gaetan Jasmin ABSTRACT: Andermann et al. described in 1972 an autosomal recessive inherited syndrome which associates agenesis of the corpus callosum, mental deficiency, and a peripheral motor deficit. We had the opportunity to study in detail 15 patients affected by this syndrome. As in the cases previously reported, the families of these children all originated from Charlevoix County and the Saguenay-Lac St-Jean area in the Province of Quebec. Clinically, these patients have a characteristic facies and moderate mental retardation associated with a progressive motor neuropathy leading to loss of ambulation by adolescence and progressive scoliosis. In 13 of these 15 patients, neuroradiological investigation has shown either total or partial agenesis of the corpus callosum. In every patient in whom these tests were done, sensory nerve action potentials were absent and motor nerve conduction velocities reduced. We also found neurogenic abnormalities both on EMG and neuromuscular biopsies. These abnormalities are similar to those described in Friedreich's ataxia and in hereditary motor and sensory neuropathy type II, although in our patients the motor deficit is much more severe than in these diseases. The pathogenesis of the peripheral nervous system involvement is still unknown since there have so far been no autopsy studies of this syndrome. RESUME: Andermann et coll. ont identifie en 1972 un syndrome hereditaire a transmission autosomale recessive associant une ag£n6sie du corps calleux a une deficience intellectuelle et a une atteinte motrice peripherique.